首页> 外文会议>International symposium on controlled release of bioactive materials >Local argatroban delivery using surface modified balloon catheter: acute in vivo results
【24h】

Local argatroban delivery using surface modified balloon catheter: acute in vivo results

机译:使用表面改性气球导管的本地Argatroban递送:体内结果急性效果

获取原文

摘要

Although percutaneous transluminal coronary angioplasty (PTCA) is commonly used, a high restenosis rate (30-50percent) remains a serious clinical problem associated with this procedure. Mural thrombosis and intimal hyperplasia are the acute and chronic complications, respectively, of PTCA-induced arterial injury. Systemic delivery of antiplatelet and antiproliferative drugs has failed to produce dramatic reductions in these complications. Therefore, local intramural delivery of these agents to the diseagsed areas is an exciting approach in preventing both early and late restenosis.
机译:虽然常用经皮透析冠状动脉血管成形术(PTCA),但高再狭窄率(30-50%)仍然是与此程序相关的严重临床问题。壁形血栓形成和内膜增生是PTCA诱导的动脉损伤的急性和慢性并发症。抗血小板和抗增殖药物的全身递送未能在这些并发症中产生显着的减少。因此,将这些药剂的局部内际迁移到剥离区域是预防早期和后期再狭窄的令人兴奋的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号